| Literature DB >> 34926848 |
Gamilah Al-Qadhi1, Marwan Mansoor Ali Mohammed2, Mohammed Al-Ak'hali3,4, Essam Ahmed Al-Moraissi5.
Abstract
BACKGROUND: Khat (Catha edulis Forsk) leaves are chewed by people in certain regions of East Africa and the Middle East for their stimulating amphetamine-like effects. The purpose of this scoping review is to systematically map the current in vitro publications that investigated the toxicological potential effects of khat on cultured human or animal cells in terms of cellular viability and activity.Entities:
Keywords: Apoptosis; Catha edulis; Cytotoxicity; Khat extract; Reactive oxygen species
Year: 2021 PMID: 34926848 PMCID: PMC8646973 DOI: 10.1016/j.heliyon.2021.e08466
Source DB: PubMed Journal: Heliyon ISSN: 2405-8440
Figure 1Flow diagram showing the different phases of literature screening for the scoping review process (Editable file: PRISMA Flow Diagram, Liberati et al., 2009).
Characteristics of included studies.
| No. | Author and year of publication | Cell line/type | Source of cells/tissue | Sex of human or origin of animal | Species Strain | Exposure | Dose | Frequency and duration of dosing | Number of replicates per group | % serum/plasma in medium |
|---|---|---|---|---|---|---|---|---|---|---|
| 1. | Al-Ahdal et al., 1988 | Epidermoid carcinoma cells (KB), normal human fibroblasts (1BR.3) & xeroderma pigmentosum fibroblasts (XP2Bi) | documented | NR | human | Fresh khat leaves | 20–200 ng/ml | 2,4,8,10 & 25h | NM | 10% fetal bovine serum (FBS) |
| 2. | Dimba et al., 2003 | Leukemia HL-60, Jurkat, NB4 cell lines | not documented | NR | not relevant | Methanolic khat extract | NM | 2 & 8 h | Triplicate & more | 10% FBS |
| 3. | Barkwan et al., 2004 | Human T lymphocyte cell line | documented | NR | human | Aqueous khat extract | 1–2000 μg/ml | 12 h | Triplicate | 10% FBS |
| 4. | Dimba et al., 2004 | Leukemia HL-60, Jurkat, NB4 cell lines & primary peripheral leukocytes | documented | NR | human | Methanolic Khat extract | 6.3–200 μg ml_1 | 0.5–8 h | Triplicate & more | 10% FBS |
| 5. | Nyongesa et al., 2006 | Mouse testes & interstitial cells | documented | 35 male | Swiss Mice | Fresh khat leaves | 0.06, 0.6, 6 30, 60 mg/ml | 0.5–3 h | Triplicates | 2% Bovine Serum Albumin |
| 6. | Lukandu et al., 2008a | Normal human oral keratinocytes & fibroblasts | documented | 16 female 19 male | human | Organic khat extract | 0, 3.16, 10, 31.6, & 100 μg/ml | 24 & 72 h (for 7 days) | Triplicate | 10 % FBS |
| 7. | Lukandu et al., 2008b | Normal human oral keratinocytes & fibroblasts | documented | 16 females 19 males | human | Organic & Aqueous khat extracts | 10, 31.6, 100 & 316 μg/ml | 4, 8 & 24 h | Triplicate & more | 10 % FBS |
| 8. | Lukandu et al., 2009 | Normal human oral keratinocytes & fibroblasts | documented | NR | human | Organic & Aqueous khat extracts | 10, 31.6, 100 & 316 μg/ml | 0.5–24 h | Triplicate | 10% FBS |
| 9. | Bredholt et al., 2009 | Monocytic Acute Myeloid Leukemia cell line (MOLM-13) & acute biphenotypic leukemia (MV-4-11) | documented | NR | human | Methanolic Khat extract | 200 μg/ml | 4, 6, 8 & 24 h | Triplicate | 10% FBS |
| 10. | Lukandu et al., 2010 | Normal human oral keratinocytes & fibroblasts | documented | NR | human | Methanolic Khat extract | 0, 3.16, 10, 31.6, & 100 μg/ml | 6 h (for 7 days) | Triplicate | 10% FBS |
| 11. | Murdoch et al., 2011 | Peripheral blood mononuclear cells (PBMCs) | documented | NR | human | Fresh khat leaves | 1–100 μg/ml | 4–24 h | Triplicate | 2% human AB serum |
| 12. | Abid et al., 2013 | L02 Hepatic cells | not documented | NR | human | Ethanolic khat extract | 10, 50 and 100 μg/ml | 4, 8, 16, 24 h | Triplicate | 10% FBS |
| 13. | Ageely et al., 2016 | Madin-Darby Bovine Kidney cell line | documented | United state | Bovine | Organic khat extract | 10, 5, 2.5, 1.25, 0.62, 0.31, & 0.15 mg/ml | 4 & 48 h | Triplicate | 10% FBS |
| 14. | Mohen et al., 2016 | H9c2 (2–1) Rat cardiomyoblast cell lines | documented | NR | mice | Methanolic khat extract | 86.5 μg/ml | 0, 24, 48 &72 h | Triplicate | 10% FBS |
| 15. | Lu et al., 2017 | human breast cancer MDA-MB-231 cell | not documented | Female | human | Ethanolic khat extract | 20, 200, 300 &400 μg/ml | 4, 8, 16 & 24 h. | Triplicate | 10% FBS |
| 16. | Abdelwahab et al., 2018 | RAW 264.7 cells (monocytic macrophages) | documented | NR | Murine mice | Methanolic khat extract | 30, 15, 7.5,3.75 μg/ml | Triplicate | 10% FBS |
Results of included studies.
| No. | Author and year of publication | Method of analysis | Outcome measures | Effect of khat | Endpoint |
|---|---|---|---|---|---|
| 1. | Al-Ahdal et al., 1988 | Colony-formation assay | Cellular viability | Reduced survival cells | Cytotoxicity |
| Assays for macro-molecule biosynthesis | DNA, RNA & protein biosynthesis | Inhibited DNA, RNA and protein synthesis, RNA was more vulnerable to the toxic effects of khat | |||
| 2. | Dimba et al., 2003 | Trypan blue dye exclusion test, chromatin condensation assay & Haemocytometer | Cellular viability | Reduced survival cells | Apoptosis |
| Transmission Electron Microscope (TEM) | Cellular ultrastructure | Induced structural changes resembling apoptosis | |||
| Western blot analysis | Caspase 3- cleavage | Data not shown | |||
| 3. | Barkwan et al., 2004 | Trypan blue dye exclusion test | Cellular viability | Reduced survival cells | Cytotoxicity Genotoxicity |
| Micronuclei assay | Clastogenic potential | Increased micronuclei frequencies | |||
| Alkaline comet assay | Detection of DNA damage | Increased DNA damage | |||
| 4. | Dimba et al., 2004 | Trypan blue dye exclusion test, chromatin condensation assay & Haemocytometer | Cellular viability | Reduced survival cells | Apoptosis |
| TEM | Cellular ultrastructure | Induced structural changes resembling apoptosis | |||
| Annexin V/Propidium Iodide (PI) staining + flow cytometery | Probe apoptotic fractions | Data not shown | |||
| Western blot analysis | Caspase 3- cleavage | Activation of caspase-3 | |||
| 5. | Nyongesa et al., 2006 | Haemocytometer | Cellular viability | Reduced survival cells | Different production of testosterone according to the dose |
| Radio-immune assay | Testosterone concentration | Impairment in reproductive function at high dose, while low concentration had a converse effect | |||
| 6. | Lukandu et al., 2008a | Trypan blue dye exclusion test & Haemocytometer | Cellular viability | Reduced survival cells | Cytotoxicity |
| Phase-contrast microscopy | Cell morphology | Induced structural changes resembling apoptosis | |||
| Flow ctometry | Cell cycle analysis | Cell cycle arrest in G1 phase | |||
| Western blot analysis | Primary antibodies: p53, p21, & p16 | Increased the expression of p53, p16, and p21 | |||
| 7. | Lukandu et al., 2008b | Trypan blue dye exclusion test, Chromatin condensation assay & Haemocytometer | Cellular viability | Reduced survival cells | Apoptosis & ROS production |
| Phase-contrast microscopy | Cell morphology | Induced structural changes resembling apoptosis | |||
| TEM | Cellular ultrastructure | Induced structural changes resembling apoptosis | |||
| Annexin V- biotin & TUNEL assay | Apoptotic fraction | Induced biochemical features resembling apoptosis | |||
| Fluorescent DNA stains | Plasma membrane permeability | DNA fragmentation | |||
| Fluorescence-activated cell sorter | Intracellular ROS & GSH | Increased ROS production and depletion of GSH | |||
| 8. | Lukandu et al., 2009 | WST-1 viability/proliferation assay Phase-contrast microscopy | Cellular viability | Reduced survival cells | Apoptosis |
| Haemocytometer | Cell attachment & number | Irreversible changes at high dose and long time | |||
| Immunofluorescence | Detection of apoptosis inducing factors (AIF) | Induced nuclear translocation Of AIF | |||
| Fluorescence-activated cell sorter | membrane potential | Decreased mitochondrial inner transmembrane potential | |||
| Western blot analysis | Expression of: anti-pro-caspase-3, anti Bcl-2 anti-AIF anti-cytochrome c | Caspase 3 not affected Decreased Bcl-2 AIF translocated from nuclear to cystolic | |||
| 9. | Bredholt et al., 2009 | WST-1 viability/proliferation assay | Cellular viability | Reduced survival cells, MV-4-11cell line exhibited more resistance to khat | Apoptosis |
| Epifluorescent microscope/Hoechst staining | Nuclear Morphology | Exhibited less sensitive to changes | |||
| TEM | Cellular ultrastructure | Degenerated mitochondria and morphological features of autophagy | |||
| High-resolution respirometry | Cellular O2 consumption rate | Impairment of mitochondrial function in MOLM-13 cells, whereas MV-4-11 cells were less affected | |||
| Western blot analysis | Protein levels of Bcl-2 and Bax | Not change | |||
| Mcl-l, Caspase-8 colorimetric kit | Caspase-8 activity | Activated caspase -8, particularly in MOLM-13 cells Reduced levels of anti-apoptotic Mcl-1 protein | |||
| RT-PCR | Expression of c-FLIPL | Induced c-FLIPL cleavage in MOLM-13, whereas no significant changes in MV-4-11 and HL-60 | |||
| 10. | Lukandu et al., 2010 | Light microscope (H&E) | Structural changes, differentiation & degree of keratinization | Decreased total epithelial thickness | Alteration of cell phenotype |
| Histomorphometric analysis | Cell proliferation | Decreased cell proliferation | |||
| immunohistochemical analyses | p21 expression | Increased p21 positive cells (premature expression) | |||
| Transglutaminase Colorimetric Microassay | Transglutaminase activity | Induced transglutaminases | |||
| Western blot analysis | Expression of: Filaggrin, Involucrin, p38, p-p38, p16 | Induced premature expression of involucrin & filaggrin Increased levels of p38 and were reversed by p38 inhibition p16 not affected | |||
| 11. | Murdoch et al., 2011 | FL2 PI channel + Flow cytometry | Cellular viability | Reduced survival cells | Cytotoxicity Apoptosis Alteration of cell phenotype and antimicrobial activity of PBMCs |
| Annexin-V/PI staining + Flow cytometry | Probe apoptotic fractions | Features of apoptosis | |||
| Immunoblotting assay | Cellular metabolic function, total cellular protein | Activated transcription factors p38 MAPK and HIF-1α but inhibited NFКB p65 | |||
| Flow cytometry | CD markers | Increased expression of PBMC surface receptors | |||
| ROS detection reagents | Level of ROS | Increased ROS production | |||
| FACS Array Bio-analyzer | Cytokine secretion | Inhibited the production of inflammatory cytokines TNF-α, IL-6 & chemokines CCL5, CXCL8 Increased production of anti-inflammatory cytokines IL-2, IL-10 IFN-y and Fas Ligand | |||
| Flow cytometry | Phagocytic activity (dextran uptake) | Inhibited phagocytosis | |||
| 12. | Abid et al., 2013 | Trypan blue dye exclusion test | Cellular viability | Reduced survival cells | Apoptosis ROS production |
| TEM | Cellular ultrastructure | Induced structural changes resembling apoptosis | |||
| Hoechst 33258 staining, Annexin V/PI staining + flow cytometry | Probe apoptotic fractions | Features of apoptosis | |||
| Western blot analysis | Apoptosis-related proteins expression | Increased Bax Decreased Bcl-2 Activated caspase 8&9 Stable FAS | |||
| Western blot analysis | MAPKs activation | Increased phosphorylation of JNK & ERK Stable p38 | |||
| Cellular DCF-DA assay | Levels of ROS | Increased ROS production | |||
| 13. | Ageely et al., 2016 | Trypan blue dye exclusion test & Haemocytometer | Cellular viability | Reduced survival cells | Apoptosis |
| Clonogenic survival assay | Cell proliferation | Inhibited cell proliferation | |||
| Phase-contrast microscopy | Cell morphology | Rounding up of cells | |||
| Light microscope/H&E staining | Cell morphology | Cells shrinkage, chromatin condensation, nucleus fragmentation | |||
| Acridine Orange (AO)/Ethidium Bromide (EB) staining + fluorescence microscope | Plasma membrane alterations & apoptotic cells | Induced morphological changes resembling apoptosis | |||
| Annexin V/PI staining + flow cytometery | Probe apoptotic fractions | Increased apoptotic bodies | |||
| 14. | Mohen et al., 2016 | MTT (Microculture tetrazolium assay) | Cellular viability | Reduced survival cells | Cytotoxicity Apoptosis ROS production |
| AO/PI staining + Fluorescence microscope | Formation of apoptotic bodies | Features of apoptosis (DNA denaturation, nuclear chromatin condensation) | |||
| ELISA assay | Expression of Bax & Bcl-2 proteins | Increased Bax Decreased Bcl-2 | |||
| luminescence-based assay | Activity of capases 3,7 | Increased activity of capases 3&7 | |||
| Cellular DCF-DA assay | Levels of ROS | Increased ROS production | |||
| 15. | Lu et al., 2017 | Trypan blue dye exclusion test | Cellular viability | Reduced survival cells | Apoptosis |
| Annexin V/PI staining + flow cytometry | Probe apoptotic fraction | Features of apoptosis (nuclear fragmentation & chromatin condensation). | |||
| Hoechst 33258/light fluorescent microscope | Assessment of apoptotic features | Features of apoptosis | |||
| TEM | Cellular ultrastructure | Induced morphological changes resembling apoptosis | |||
| Western blot analysis | Expression of Caspase-9, Bcl-2, Bax proteins & the activation of MAPKs | Caspase -9 not detected Increased Bax Decreased Bcl-2 Increased JNK & ERK | |||
| Cellular DCF-DA assay | Levels of ROS | Decreased ROS production | |||
| 16. | Abdelwahab et al., 2018 | MTT assay | Cellular viability | Reduced survival cells | Cytotoxicity |
| DPPH, ORAC & FRAP assays | Antioxidant activity | High antioxidant potency. | |||
| Griess reaction | Inflammation/Nitric oxide (NO) production | Inhibited NO pro-inflammatory production | |||
| Cellular DCF-DA assay | Levels of ROS | Decreased ROS production |
Figure 2Possible toxicological effects of khat on cultured cells.